Biomarin Pharmaceutical - Registered Shares OverviewBiomarin Pharmaceutical - Registered Shares EBIT
EBIT (Earnings Before Interest and Taxes) analysis for BMRN.
Quarterly EBIT
$156.16M
↓ 33.61% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$403.23M
↓ 99.65% YoY
Trailing 12 months ending Mar 31, 2026